March 12, 2008, University Park, PA--A team of Penn State researchers has used fluorescence lifetime imaging to be the first to demonstrate that lipid molecules in cell membranes participate in mammals' reactions to allergens in a living cell. The finding will help scientists better understand how allergy symptoms are triggered and could contribute to the creation of improved drugs to treat them. The work will be reported in the March 14 issue of the Journal of Biological Chemistry.
The team studied clusters of cholesterol-rich lipid molecules that they believe serve as platforms for the receptors that receive antibodies, the proteins that protect the body from allergens. In this case, the team examined IgE antibodies, which upon binding to their receptors initiate a cell's release of histamine -- the substance that causes the unpleasant, but beneficial, mucous production, congestion and itchiness associated with allergies.
"This research is basically the molecular foundation for why many people sneeze in the spring," said Ahmed Heikal, an associate professor in the Department of Bioengineering and a leader of the project.
While the idea that lipid clusters (lipid domains) are involved in the allergic response is not new, the Penn State team is the first to document this connection in a living cell under physiological conditions.
"No one has observed the domains in action because they are too small and too transient (held together by very weak molecular interactions) to be viewed with a light microscope," said Erin Sheets, a Penn State assistant professor of chemistry who also is a leader of the project.
"To overcome this challenge," added Heikal, "we used a combination of imaging and spectroscopy techniques that we are developing in our laboratories."
In their experiment, the researchers first labeled the cell membrane and IgE antibodies with two different fluorescent tags. Next, they introduced an allergen and watched as it bound to receptors on the cell membrane, thus initiating an allergic response. To demonstrate that this activity was taking place within the lipid domain, the researchers used fluorescence lifetime imaging.
"We previously showed that our fluorescently labeled membrane probe has a longer lifetime within a cholesterol-rich lipid domain," said Sheets. "Here we show that changes in this lifetime follow the changes that occur during the first steps in the allergic response process. Our results also show that lipid domains in the cell membrane associate with IgE antibodies and their receptors in the initial stages of an allergic reaction."
In the future, Sheets and Heikal plan to apply the team's discoveries to a project involving aging. During the aging process, T cells, which protect the body from foreign substances like viruses and cancer cells, can lose their ability to signal effectively. Sheets and Heikal plan to use these fluorescence-lifetime imaging tools to examine the structure and integrity of T-cell membranes with a goal of determining why they lose their knack for signalling and how this problem can be corrected.
"We want to compare the effectiveness of signaling in young T cells, which clear out debris quickly, to old T cells, which are not as efficient," said Sheets. "I think it will be a pretty cool application of our technique."
Other Penn State scientists who contributed to this research include Angel Davey and Keith Krise, both doctoral degree students in the Department of Chemistry. The work was funded by Penn State, the National Science Foundation, the Commonwealth of Pennsylvania, the American Chemical Society and the National Institutes of Health.